Regulation of CC chemokine receptor 5 in hepatitis G virus infection

AIDS

Volumn 17, Issue 10, 2003, Pages 1457-1462

  Nattermann, Jacob ^a   Nischalke, Hans Dieter ^a   Kupfer, Bernd ^a   Rockstroh, Jürgen ^a   Hess, Lothar ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CC chemokine receptor 5; CC chemokines; CD81; Hepatitis G virus; HIV

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; CD8 ANTIGEN; CD81 ANTIGEN; CHEMOKINE RECEPTOR CCR5; RANTES; VIRUS PROTEIN;

ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; EPIDEMIOLOGICAL DATA; FLOW CYTOMETRY; GENE CONTROL; HEPATITIS G; HEPATITIS G VIRUS; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; VIRUS CELL INTERACTION; WILD TYPE;

ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FLAVIVIRIDAE INFECTIONS; FLOW CYTOMETRY; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MEMBRANE PROTEINS; PROTEIN BINDING; RANTES; RECEPTORS, CCR5; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS;

EID: 0041367051     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200307040-00006     Document Type: Article

References (19)

1. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995, 92:3401-3405.
2. Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis 2001, 33:572-580.
3. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001, 345:715-724.
4. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001, 345:707-714.
5. Eugen-Olsen J, Iversen AK, Garred P, Koppelhus U, Pedersen C, Benfield TL, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS- free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997, 11:305-310.
6. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997, 3:338-340.
7. Brandt SM, Mariani R, Holland AU, Hope TJ, Landau NR. Association of chemokine-mediated block to HIV entry with coreceptor internalization. J Biol Chem 2002, 277:17291-17299.
8. Lichterfeld M, Leifeld L, Nischalke HD, Rockstroh JK, Hess L, Sauerbruch T, et al. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 2002, 185:1803-1807.
9. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998, 282:938-941.
10. Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998, 16:89-109.
11. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002, 195:43-49.
12. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 2001, 31:166-175.
13. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002, 195:35-41.
14. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996, 93:1759-1763.
15. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
16. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996, 273:1856-1862.
17. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, et al. Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci USA 2000, 97:13812-13817.
18. Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 1997, 234:340-348.
19. Vallet S, Dorval Y, Perfezov P, Corrèze P, Pasquier E, De Saint Martin L. A link between GB virus C infection and CCR5 genotype among the HIV infected patients. In: 42nd International Conference on Antimicrobial Agents Chemotherapy. San Diego, CA, USA, 27-30, September 2002 [abstract H-1742].